立他司特是整合素淋巴细胞功能相关抗原-1(LFA-1)的拮抗剂; 抑制Jurkat T细胞附着于ICAM-1的IC50为2.98nM，FDA批准的药物用于干眼的症状和体征的综合征的治疗，称为干燥性角结膜炎，通过抑制炎性细胞结合减少炎症。它经常被用来与环孢素（ikervis或restasis）干眼症的治疗包括睑板腺功能障碍和炎症性干眼。
Boc-Phe(3-Br)-OH
Benzofuran-6-ol
(S)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride
Methyl benzofuran-6-carboxylate
6-Hydroxybenzofuran-3(2H)-one
3,5-Dichlorobenzaldehyde
Benzofuran-6-carboxylic acid
(S)-2-Amino-3-(3-bromophenyl)propanoic acid
(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid
5,7-Dichloro-1,2,3,4-tetrahydroisoquinoline
Benzofuran-6-yl trifluoromethanesulfonate
6-((tert-Butyldimethylsilyl)oxy)benzofuran-3(2H)-one
5,7-Dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid
5,7-Dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline
N-Boc-3-(methylsulfonyl)-L-phenylalanine Benzyl Ester
Benzyl (S)-2-(5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride
Benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate
(S)-2-((tert-Butoxycarbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid
